uracil has been researched along with Bipolar Disorder in 2 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xu, XJ | 1 |
Zheng, P | 2 |
Ren, GP | 1 |
Liu, ML | 1 |
Mu, J | 2 |
Guo, J | 1 |
Cao, D | 1 |
Liu, Z | 2 |
Meng, HQ | 1 |
Xie, P | 2 |
Chen, JJ | 1 |
Zhou, CJ | 1 |
Fu, YY | 1 |
Yang, DY | 1 |
Li, Q | 1 |
Wei, YD | 1 |
Zhou, JJ | 1 |
Huang, H | 1 |
2 other studies available for uracil and Bipolar Disorder
Article | Year |
---|---|
2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.
Topics: Adult; Biomarkers; Bipolar Disorder; Body Mass Index; Female; Gas Chromatography-Mass Spectrometry; | 2014 |
Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Topics: Adult; beta-Alanine; Biomarkers; Bipolar Disorder; Depressive Disorder, Major; Diagnosis, Differenti | 2015 |